H. Ross and P. Argani, Xp11 translocation renal cell carcinoma, Pathology, vol.42, issue.4, pp.369-373, 2010.
DOI : 10.3109/00313021003767348

A. Folpe and A. Deyrup, Alveolar soft-part sarcoma: a review and update, Journal of Clinical Pathology, vol.59, issue.11, pp.1127-1132, 2006.
DOI : 10.1136/jcp.2005.031120
URL : http://jcp.bmj.com/content/jclinpath/59/11/1127.full.pdf

P. Argani, S. Aulmann, P. Illei, G. Netto, J. Ro et al., A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions, The American Journal of Surgical Pathology, vol.34, issue.10, pp.1395-1406, 2010.
DOI : 10.1097/PAS.0b013e3181f17ac0

C. Antonescu, L. Loarer, F. Mosquera, J. Sboner, A. Zhang et al., fusion defines a distinct subset of epithelioid hemangioendothelioma, Genes, Chromosomes and Cancer, vol.24, issue.8, pp.775-784, 2013.
DOI : 10.1101/gad.1843810

S. Kim, Y. Choi, H. Jeong, K. Lee, J. Chae et al., Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma, Virchows Archiv, vol.34, issue.10, pp.299-306, 2011.
DOI : 10.1097/PAS.0b013e3181f17ac0

S. Macher-goeppinger, W. Roth, N. Wagener, M. Hohenfellner, R. Penzel et al., Molecular heterogeneity of TFE3 activation in renal cell carcinomas, Modern Pathology, vol.13, pp.308-315, 2012.
DOI : 10.1158/0008-5472.CAN-06-2855

G. Malouf, F. Monzon, J. Couturier, V. Molinié, B. Escudier et al., Genomic Heterogeneity of Translocation Renal Cell Carcinoma, Clinical Cancer Research, vol.19, issue.17, pp.4673-4684, 2013.
DOI : 10.1158/1078-0432.CCR-12-3825
URL : http://clincancerres.aacrjournals.org/content/clincanres/19/17/4673.full.pdf

J. Mosquera, P. Dal-cin, K. Mertz, S. Perner, I. Davis et al., Validation of a TFE3 Break-apart FISH Assay for Xp11.2 Translocation Renal Cell Carcinomas, Diagnostic Molecular Pathology, vol.20, issue.3, pp.129-137, 2011.
DOI : 10.1097/PDM.0b013e31820e9c67

M. Berger, M. Lawrence, F. Demichelis, Y. Drier, K. Cibulskis et al., The genomic complexity of primary human prostate cancer, Nature, vol.22, issue.7333, pp.214-220, 2011.
DOI : 10.1038/modpathol.2009.69

P. Campbell, S. Yachida, L. Mudie, P. Stephens, E. Pleasance et al., The patterns and dynamics of genomic instability in metastatic pancreatic cancer, Nature, vol.22, issue.7319, pp.1109-1113, 2010.
DOI : 10.1038/nature09460

M. Berger, J. Levin, K. Vijayendran, A. Sivachenko, X. Adiconis et al., Integrative analysis of the melanoma transcriptome, Genome Research, vol.20, issue.4, pp.413-427, 2010.
DOI : 10.1101/gr.103697.109

C. Maher, N. Palanisamy, J. Brenner, X. Cao, S. Kalyana-sundaram et al., Chimeric transcript discovery by paired-end transcriptome sequencing, Proceedings of the National Academy of Sciences, vol.68, issue.18, pp.12353-12358, 2009.
DOI : 10.1158/0008-5472.CAN-08-2014
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708976

D. Pflueger, S. Terry, A. Sboner, L. Habegger, R. Esgueva et al., Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing, Genome Research, vol.21, issue.1, 2011.
DOI : 10.1101/gr.110684.110

G. Guo, Y. Gui, S. Gao, A. Tang, X. Hu et al., Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma, Nature Genetics, vol.44, issue.1, pp.17-19, 2012.
DOI : 10.1146/annurev.med.042808.171650

I. Varela, P. Tarpey, K. Raine, D. Huang, C. Ong et al., Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma, Nature, vol.133, issue.7331, pp.539-542, 2011.
DOI : 10.1016/j.cell.2008.03.021

P. Camparo, V. Vasiliu, V. Molinie, J. Couturier, K. Dykema et al., Renal Translocation Carcinomas, The American Journal of Surgical Pathology, vol.32, issue.5, pp.656-670, 2008.
DOI : 10.1097/PAS.0b013e3181609914

A. Sboner, L. Habegger, D. Pflueger, S. Terry, D. Chen et al., FusionSeq: a modular framework for finding gene fusions by analyzing Paired-End RNA-Sequencing data, Genome Biology, vol.11, issue.10, p.104, 2010.
DOI : 10.1186/gb-2010-11-10-r104
URL : https://genomebiology.biomedcentral.com/track/pdf/10.1186/gb-2010-11-10-r104?site=genomebiology.biomedcentral.com

E. Bruder, H. Moch, D. Ehrlich, I. Leuschner, D. Harms et al., Wnt signaling pathway analysis in renal cell carcinoma in young patients, Modern Pathology, vol.7, issue.12, pp.1217-1229, 2007.
DOI : 10.1073/pnas.0606850103

E. Bruder, O. Passera, D. Harms, I. Leuschner, M. Ladanyi et al., Morphologic and Molecular Characterization of Renal Cell Carcinoma in Children and Young Adults, The American Journal of Surgical Pathology, vol.28, issue.9, pp.1117-1132, 2004.
DOI : 10.1097/01.pas.0000131558.32412.40

K. Mertz, F. Demichelis, R. Kim, P. Schraml, M. Storz et al., Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer, Human Pathology, vol.38, issue.10, pp.1454-1462, 2007.
DOI : 10.1016/j.humpath.2007.05.017

L. Habegger, A. Sboner, T. Gianoulis, J. Rozowsky, A. Agarwal et al., RSEQtools: a modular framework to analyze RNA-Seq data using compact, anonymized data summaries, Bioinformatics, vol.27, issue.2, pp.281-283, 2011.
DOI : 10.1093/bioinformatics/btq643
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018817

A. Mortazavi, B. Williams, K. Mccue, L. Schaeffer, and B. Wold, Mapping and quantifying mammalian transcriptomes by RNA-Seq, Nature Methods, vol.14, issue.7, pp.621-628, 2008.
DOI : 10.1128/MCB.14.3.1647

G. Dalgliesh, K. Furge, C. Greenman, L. Chen, G. Bignell et al., Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes, Nature, vol.6, issue.7279, pp.360-363, 2010.
DOI : 10.1038/nature08672

M. Kircher, U. Stenzel, and J. Kelso, Improved base calling for the Illumina Genome Analyzer using machine learning strategies, Genome Biology, vol.10, issue.8, p.83, 2009.
DOI : 10.1186/gb-2009-10-8-r83
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745764

M. Rechsteiner, A. Von-teichman, A. Nowicka, T. Sulser, P. Schraml et al., VHL Gene Mutations and Their Effects on Hypoxia Inducible Factor HIF??: Identification of Potential Driver and Passenger Mutations, Cancer Research, vol.71, issue.16, pp.5500-5511, 2011.
DOI : 10.1158/0008-5472.CAN-11-0757

B. Bode, S. Frigerio, S. Behnke, B. Senn, B. Odermatt et al., Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma, Modern Pathology, vol.97, issue.4, pp.541-547, 2006.
DOI : 10.1073/pnas.0405220101

P. Argani, S. Olgac, S. Tickoo, M. Goldfischer, H. Moch et al., Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum, The American Journal of Surgical Pathology, vol.31, issue.8, pp.1149-1160, 2007.
DOI : 10.1097/PAS.0b013e318031ffff

G. Martignoni, S. Gobbo, P. Camparo, M. Brunelli, E. Munari et al., Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions, Modern Pathology, vol.22, issue.1, pp.1313-1319, 2011.
DOI : 10.1038/sj.onc.1206686

M. Zhong, D. Angelo, P. Osborne, L. Paniz-mondolfi, A. Geller et al., Translocation Renal Cell Carcinomas in Adults, The American Journal of Surgical Pathology, vol.36, issue.5, pp.654-662, 2012.
DOI : 10.1097/PAS.0b013e31824f24a6
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527899

M. Tanaka, K. Kato, K. Gomi, M. Matsumoto, H. Kudo et al., Perivascular Epithelioid Cell Tumor With SFPQ/PSF-TFE3 Gene Fusion in a Patient With Advanced Neuroblastoma, The American Journal of Surgical Pathology, vol.33, issue.9, pp.1416-1420, 2009.
DOI : 10.1097/PAS.0b013e3181a9cd6c

C. Maher, C. Kumar-sinha, X. Cao, S. Kalyana-sundaram, B. Han et al., Transcriptome sequencing to detect gene fusions in cancer, Nature, vol.3, issue.7234, pp.97-101, 2009.
DOI : 10.1101/gr.229202. Article published online before March 2002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725402

D. Rickman, D. Pflueger, B. Moss, V. Vandoren, C. Chen et al., SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation-Specific Fusion Transcript in Prostate Cancer, Cancer Research, vol.69, issue.7, pp.2734-2738, 2009.
DOI : 10.1158/0008-5472.CAN-08-4926

X. Wang, R. Yang, S. Jadhao, D. Yu, H. Hu et al., Transmembrane Emp24 Protein Transport Domain 6 is Selectively Expressed in Pancreatic Islets and Implicated in Insulin Secretion and Diabetes, Pancreas, vol.41, issue.1, pp.10-14, 2012.
DOI : 10.1097/MPA.0b013e318223c7e4
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870856

R. Smith and V. Lupashin, Role of the conserved oligomeric Golgi (COG) complex in protein glycosylation, Carbohydrate Research, vol.343, issue.12, pp.2024-2031, 2008.
DOI : 10.1016/j.carres.2008.01.034

V. Tomlinson, H. Newbery, N. Wray, J. Jackson, A. Larionov et al., Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours, BMC Cancer, vol.276, issue.11, 2005.
DOI : 10.1074/jbc.M006824200

V. Tomlinson, H. Newbery, J. Bergmann, J. Boyd, D. Scott et al., Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus, British Journal of Cancer, vol.28, issue.10, pp.1613-1620, 2007.
DOI : 10.1186/1471-2407-5-113

B. Scaggiante, B. Dapas, S. Bonin, M. Grassi, C. Zennaro et al., Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression, British Journal of Cancer, vol.15, issue.1, pp.166-173, 2012.
DOI : 10.1161/CIRCRESAHA.108.173963

Y. Shimoda and K. Watanabe, Contactins, Cell Adhesion & Migration, vol.140, issue.1, pp.64-70, 2009.
DOI : 10.1016/j.ajhg.2007.09.015

P. Argani, C. Antonescu, P. Illei, M. Lui, C. Timmons et al., Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma, The American Journal of Pathology, vol.159, issue.1, pp.179-192, 2001.
DOI : 10.1016/S0002-9440(10)61684-7

P. Argani, P. Lal, B. Hutchinson, M. Lui, V. Reuter et al., Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions, The American Journal of Surgical Pathology, vol.27, issue.6, pp.750-761, 2003.
DOI : 10.1097/00000478-200306000-00005

W. Green, R. Yonescu, L. Morsberger, K. Morris, G. Netto et al., Utilization of a TFE3 Break-apart FISH Assay in a Renal Tumor Consultation Service, The American Journal of Surgical Pathology, vol.37, issue.8, pp.1150-1163, 2013.
DOI : 10.1097/PAS.0b013e31828a69ae

L. Schmidt, F. Duh, F. Chen, T. Kishida, G. Glenn et al., Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas, Nature Genetics, vol.4, issue.1, pp.68-73, 1997.
DOI : 10.1038/ng1295-402

S. Minner, D. Rump, P. Tennstedt, R. Simon, E. Burandt et al., Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma, Cancer, vol.293, issue.2 pt 1, pp.1268-1275, 2012.
DOI : 10.1016/j.canlet.2009.11.024